About Cerulean Pharma
Cerulean Pharma is a company based in Cambridge (United States) founded in 2006 was acquired by Daré Bioscience in March 2017. Cerulean Pharma has raised $88.7 million across 11 funding rounds from investors including ARE, Bessemer Venture Partners and Daré Bioscience. The company has 20 employees as of December 31, 2016. Cerulean Pharma offers products and services including Prescription Medications, Over-the-Counter Drugs, and Generic Drugs. Cerulean Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 20 as on 31 Dec, 2016
- Stage Public
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cerulean Pharma Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.7 M (USD)
in 11 rounds
-
Latest Funding Round
Not available
-
Investors
ARE
& 7 more
-
Employee Count
20
as on Dec 31, 2016
-
Acquired by
Daré Bioscience
(Mar 19, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerulean Pharma
Cerulean Pharma offers a comprehensive portfolio of products and services, including Prescription Medications, Over-the-Counter Drugs, and Generic Drugs.
Platform for ordering and delivering regulated prescription drugs securely.
Sale of non-prescription items like vitamins and analgesics for daily use.
Lower-cost alternatives to brand drugs for various health conditions.
Funding Insights of Cerulean Pharma
Cerulean Pharma has successfully raised a total of $88.7M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cerulean Pharma
Cerulean Pharma has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Bessemer Venture Partners and Daré Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked | |
|
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
|
Locked | Locked | Locked | |
|
Early-stage life sciences investments are targeted in the healthcare sector.
|
Locked | Locked | Locked |
Investor details for Cerulean Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cerulean Pharma
Investment portfolio details for Cerulean Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cerulean Pharma
Detailed financials for Cerulean Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cerulean Pharma Comparisons
Peer comparison for Cerulean Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cerulean Pharma
Cerulean Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Moderna, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Cerulean Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cerulean Pharma
Complete news archive for Cerulean Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerulean Pharma
Cerulean Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Cerulean Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Cerulean Pharma is a funded company, having raised a total of $88.7M across 11 funding rounds to date.
As of Dec 31, 2016, the latest employee count at Cerulean Pharma is 20.
Cerulean Pharma, formerly Tempo Pharmaceuticals, is a privately-held biopharmaceutical company focused on the development of novel nanotechnology-based therapeutics in the areas of oncology, cardiovascular, autoimmune and inflammatory diseases. The company has a Dynamic Tumor Targeting Platform to create a portfolio of nanoparticle-drug conjugates, or NDCs, designed to selectively attack tumor cells, reduce toxicity by sparing the bodys normal cells, and enable therapeutic combinations.Their lead product candidate, CRLX101, is in multiple clinical trials with other cancer treatments as part of a combination therapy.
Cerulean Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Cerulean Pharma offers Prescription Medications, Over-the-Counter Drugs, and Generic Drugs.
Cerulean Pharma has 8 investors. Key investors include ARE, Bessemer Venture Partners, Daré Bioscience, Hercules Capital, and Lilly Ventures.